BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim G, Kang SH, Kim MY, Baik SK. Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis. PLoS One. 2017;12:e0186990. [PMID: 29065187 DOI: 10.1371/journal.pone.0186990] [Cited by in Crossref: 97] [Cited by in F6Publishing: 144] [Article Influence: 19.4] [Reference Citation Analysis]
Number Citing Articles
1 Hentschel F, Schwarz T, Lüth S, Schreyer AG. Psoas muscle index predicts time to rehospitalization in liver cirrhosis: An observational study. Medicine (Baltimore) 2022;101:e30259. [PMID: 36086704 DOI: 10.1097/MD.0000000000030259] [Reference Citation Analysis]
2 Johnston HE, Takefala TG, Kelly JT, Keating SE, Coombes JS, Macdonald GA, Hickman IJ, Mayr HL. The Effect of Diet and Exercise Interventions on Body Composition in Liver Cirrhosis: A Systematic Review. Nutrients 2022;14:3365. [DOI: 10.3390/nu14163365] [Reference Citation Analysis]
3 Bischoff SC, Barazzoni R, Busetto L, Campmans-Kuijpers M, Cardinale V, Chermesh I, Eshraghian A, Kani HT, Khannoussi W, Lacaze L, Léon-Sanz M, Mendive JM, Müller MW, Ockenga J, Tacke F, Thorell A, Vranesic Bender D, Weimann A, Cuerda C. European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline. United European Gastroenterol J 2022. [PMID: 35959597 DOI: 10.1002/ueg2.12280] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Dhariwal S, Roy A, Taneja S, Bansal A, Gorsi U, Singh S, De A, Verma N, Premkumar M, Duseja A, Dhiman R, Singh V. Assessment of Sarcopenia Using Muscle Ultrasound in Patients With Cirrhosis and Sarcopenic Obesity (AMUSE STUDY). J Clin Gastroenterol 2022. [PMID: 35943413 DOI: 10.1097/MCG.0000000000001745] [Reference Citation Analysis]
5 Hey P, Hoermann R, Gow P, Hanrahan TP, Testro AG, Apostolov R, Sinclair M. Reduced upper limb lean mass on dual energy X-ray absorptiometry predicts adverse outcomes in male liver transplant recipients. World J Transplant 2022; 12(6): 120-130 [DOI: 10.5500/wjt.v12.i6.120] [Reference Citation Analysis]
6 Espina S, Sanz-paris A, Gonzalez-irazabal Y, Pérez-matute P, Andrade F, Garcia-rodriguez B, Carpéné C, Zakaroff A, Bernal-monterde V, Fuentes-olmo J, Arbones-mainar JM. Randomized Clinical Trial: Effects of β-Hydroxy-β-Methylbutyrate (HMB)-Enriched vs. HMB-Free Oral Nutritional Supplementation in Malnourished Cirrhotic Patients. Nutrients 2022;14:2344. [DOI: 10.3390/nu14112344] [Reference Citation Analysis]
7 Tergast TL, Griemsmann M, Stockhoff L, Heidrich B, Schirmer H, Lenzen H, Wedemeyer H, Cornberg M, Jaeckel E, Maasoumy B. Home-based, tunnelled peritoneal drainage system as an alternative treatment option for patients with refractory ascites. Aliment Pharmacol Ther 2022. [PMID: 35656633 DOI: 10.1111/apt.17066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Faccioli J, Nardelli S, Gioia S, Riggio O, Ridola L. Nutrition Assessment and Management in Patients with Cirrhosis and Cognitive Impairment: A Comprehensive Review of Literature. J Clin Med 2022;11:2842. [PMID: 35628968 DOI: 10.3390/jcm11102842] [Reference Citation Analysis]
9 Al Saedi A, Kirk B, Iuliano S, Zanker J, Vogrin S, Jayaram L, Thomas S, Golding C, Navarro-Perez D, Marusic P, Leng S, Nanan R, Duque G. Effects of 3 months of multi-nutrient supplementation on the immune system and muscle and respiratory function of older adults in aged care (The Pomerium Study): protocol for a randomised controlled trial. BMJ Open 2022;12:e059075. [PMID: 35523505 DOI: 10.1136/bmjopen-2021-059075] [Reference Citation Analysis]
10 Faron A, Abu-Omar J, Chang J, Böhling N, Sprinkart AM, Attenberger U, Rockstroh JK, Luu AM, Jansen C, Strassburg CP, Trebicka J, Luetkens J, Praktiknjo M. Combination of Fat-Free Muscle Index and Total Spontaneous Portosystemic Shunt Area Identifies High-Risk Cirrhosis Patients. Front Med (Lausanne) 2022;9:831005. [PMID: 35492329 DOI: 10.3389/fmed.2022.831005] [Reference Citation Analysis]
11 Tan H, Gao X, Li X, Huang Y, Cao Q, Wan T. Sarcopenia in Patients With Spinal Metastasis: A Systematic Review and Meta-Analysis of Retrospective Cohort Studies. Front Oncol 2022;12:864501. [PMID: 35480101 DOI: 10.3389/fonc.2022.864501] [Reference Citation Analysis]
12 Pugliese N, Arcari I, Aghemo A, Lania AG, Lleo A, Mazziotti G. Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges . World J Gastroenterol 2022; 28(14): 1430-1443 [DOI: 10.3748/wjg.v28.i14.1430] [Reference Citation Analysis]
13 Luengpradidgun L, Chamroonkul N, Sripongpun P, Kaewdech A, Tanutit P, Ina N, Piratvisuth T. Utility of handgrip strength (HGS) and bioelectrical impedance analysis (BIA) in the diagnosis of sarcopenia in cirrhotic patients. BMC Gastroenterol 2022;22:159. [PMID: 35354434 DOI: 10.1186/s12876-022-02236-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Allen SL, Seabright AP, Quinlan JI, Dhaliwal A, Williams FR, Fine NHF, Hodson DJ, Armstrong MJ, Elsharkaway AM, Greig CA, Lai Y, Lord JM, Lavery GG, Breen L. The Effect of Ex Vivo Human Serum from Liver Disease Patients on Cellular Protein Synthesis and Growth. Cells 2022;11:1098. [DOI: 10.3390/cells11071098] [Reference Citation Analysis]
15 Yamamoto K, Ishizu Y, Honda T, Ito T, Imai N, Nakamura M, Kawashima H, Kitaura Y, Ishigami M, Fujishiro M. Patients with low muscle mass have characteristic microbiome with low potential for amino acid synthesis in chronic liver disease. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-07810-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Quinlan JI, Dhaliwal A, Williams F, Allen SL, Breen L, Greig CA, Lord JM, Armstrong MJ, Elsharkawy AM. Feasibility, Efficacy, and Safety of Percutaneous Muscle Biopsies in Patients With Chronic Liver Disease. Front Physiol 2021;12:817152. [PMID: 35242045 DOI: 10.3389/fphys.2021.817152] [Reference Citation Analysis]
17 Xu M, Li T, Kong M, Geng N, Song W, Guo G, Duan Z, Han Y, Chen Y. Psoas Muscle Index Can Be Used to Predict Long-Term Mortality in Young Male Patients With Acute-on-Chronic Liver Failure. Front Nutr 2022;9:811826. [DOI: 10.3389/fnut.2022.811826] [Reference Citation Analysis]
18 Meyer HJ, Wienke A, Surov A. Computed tomography-defined body composition as prognostic markers for unfavourable outcomes and in-hospital mortality in coronavirus disease 2019. J Cachexia Sarcopenia Muscle 2022;13:159-68. [PMID: 35018725 DOI: 10.1002/jcsm.12868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Di Cola S, Nardelli S, Ridola L, Gioia S, Riggio O, Merli M. Ammonia and the Muscle: An Emerging Point of View on Hepatic Encephalopathy. J Clin Med 2022;11:611. [PMID: 35160063 DOI: 10.3390/jcm11030611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Zhang B, Cai W, Gao F, Lin X, Qian T, Gu K, Song B, Chen T. Prediction of Patient Survival with Psoas Muscle Density Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Cohort Study. Med Sci Monit 2022;28:e934057. [PMID: 35031594 DOI: 10.12659/MSM.934057] [Reference Citation Analysis]
21 Núñez-Cortés R, Cruz-Montecinos C, Martinez-Arnau F, Torres-Castro R, Zamora-Risco E, Pérez-Alenda S, Andersen LL, Calatayud J, Arana E. 30 s sit-to-stand power is positively associated with chest muscle thickness in COVID-19 survivors. Chron Respir Dis 2022;19:14799731221114263. [PMID: 35957593 DOI: 10.1177/14799731221114263] [Reference Citation Analysis]
22 McBee MP, Woodhouse C, Trout AT, Geller JI, Smith EA, Zhang B, Towbin AJ. Skeletal muscle mass as a marker to predict outcomes in children and young adults with cancer. Abdom Radiol (NY) 2022;47:452-9. [PMID: 34625830 DOI: 10.1007/s00261-021-03301-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Dai X, Gao B, Zhang XX, Li J, Jiang WT. Value of the controlling nutritional status score and psoas muscle thickness per height in predicting prognosis in liver transplantation. World J Clin Cases 2021; 9(35): 10871-10883 [DOI: 10.12998/wjcc.v9.i35.10871] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kremer WM, Labenz C, Kuchen R, Sagoschen I, Bodenstein M, Schreiner O, Wörns MA, Sivanathan V, Weinmann A, Galle PR, Sprinzl MF. Sonographic assessment of low muscle quantity identifies mortality risk during COVID-19: a prospective single-centre study. J Cachexia Sarcopenia Muscle 2021. [PMID: 34881516 DOI: 10.1002/jcsm.12862] [Reference Citation Analysis]
25 Amevor AA, Yodoshi T, Trout AT, Dillman JR, Singh R, Jarvis R, Fei L, Liu C, Taylor A, Miethke A, Mouzaki M. Sarcopenia is highly prevalent in children with autoimmune liver diseases and is linked to visceral fat and parent-perceived general health. Liver Int 2021. [PMID: 34817929 DOI: 10.1111/liv.15108] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
26 Mihai F, Trifan A, Stanciu C, Huiban L, Muzîca C, Lupașcu-Ursulescu C, Negru D, Savin ML, Gîrleanu I, Cuciureanu T, Sîngeap AM. L3 Skeletal Muscle Index Dynamics in Patients with HCV-Related Compensated Cirrhosis Following Sustained Virological Response after Direct Acting Antiviral Treatment. Medicina (Kaunas) 2021;57:1226. [PMID: 34833444 DOI: 10.3390/medicina57111226] [Reference Citation Analysis]
27 Topan MM, Sporea I, Dănilă M, Popescu A, Ghiuchici AM, Lupuşoru R, Şirli R. Impact of Sarcopenia on Survival and Clinical Outcomes in Patients With Liver Cirrhosis. Front Nutr 2021;8:766451. [PMID: 34746216 DOI: 10.3389/fnut.2021.766451] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
28 Pasmans K, Adriaens ME, Olinga P, Langen R, Rensen SS, Schaap FG, Olde Damink SWM, Caiment F, van Loon LJC, Blaak EE, Meex RCR. Hepatic Steatosis Contributes to the Development of Muscle Atrophy via Inter-Organ Crosstalk. Front Endocrinol (Lausanne) 2021;12:733625. [PMID: 34707570 DOI: 10.3389/fendo.2021.733625] [Reference Citation Analysis]
29 Hsu CF, Huang CC, Liu TT, Yang UC, Liu CW, Huang SF, Yang YY, Huang YH, Hou MC, Lin HC. Deletion of intestinal SIRT1 exacerbated muscle wasting in cirrhotic mice by decreasing the intestinal concentration of short-chain fatty acids and inflammation. J Pharmacol Sci 2021;147:376-85. [PMID: 34663520 DOI: 10.1016/j.jphs.2021.09.003] [Reference Citation Analysis]
30 Ito T, Guorgui J, Markovic D, Coy H, Younan SM, DiNorcia J 3rd, Agopian VG, Farmer DG, Raman SS, Busuttil RW, Kaldas FM. Sarcopenia in high acuity liver transplantation: Does it predict outcomes? Clin Transplant 2021;:e14503. [PMID: 34634157 DOI: 10.1111/ctr.14503] [Reference Citation Analysis]
31 Czarnecka K, Czarnecka P, Tronina O, Bączkowska T, Durlik M. Multidirectional facets of obesity management in the metabolic syndrome population after liver transplantation. Immun Inflamm Dis 2021. [PMID: 34598315 DOI: 10.1002/iid3.538] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Yajima T, Arao M, Yajima K, Takahashi H. Usefulness of computed tomography-measured psoas muscle thickness per height for predicting mortality in patients undergoing hemodialysis. Sci Rep 2021;11:19070. [PMID: 34561527 DOI: 10.1038/s41598-021-98613-5] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
33 Skrzypczak D, Skrzypczak-Zielińska M, Ratajczak AE, Szymczak-Tomczak A, Eder P, Słomski R, Dobrowolska A, Krela-Kaźmierczak I. Myostatin and Follistatin-New Kids on the Block in the Diagnosis of Sarcopenia in IBD and Possible Therapeutic Implications. Biomedicines 2021;9:1301. [PMID: 34680417 DOI: 10.3390/biomedicines9101301] [Reference Citation Analysis]
34 Hsu CS, Kao JH. Management of non-alcoholic fatty liver disease in patients with sarcopenia. Expert Opin Pharmacother 2021;:1-13. [PMID: 34541964 DOI: 10.1080/14656566.2021.1978978] [Reference Citation Analysis]
35 Ebeling PR, Nguyen HH, Aleksova J, Vincent AJ, Wong P, Milat F. Secondary Osteoporosis. Endocr Rev 2021:bnab028. [PMID: 34476488 DOI: 10.1210/endrev/bnab028] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
36 Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, Carey EJ. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1611-44. [PMID: 34233031 DOI: 10.1002/hep.32049] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 39.0] [Reference Citation Analysis]
37 Saeki C, Tsubota A. Influencing Factors and Molecular Pathogenesis of Sarcopenia and Osteosarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:899. [PMID: 34575048 DOI: 10.3390/life11090899] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
38 Sidhu SS, Saggar K, Goyal O, Varshney T, Kishore H, Bansal N, Sidhu SS. Muscle strength and physical performance, rather than muscle mass, correlate with mortality in end-stage liver disease. Eur J Gastroenterol Hepatol 2021;33:555-64. [PMID: 32433422 DOI: 10.1097/MEG.0000000000001761] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
39 Ohashi K, Ito M, Kawakubo M, Sato I. Evaluation of and Intervention for Sarcopenia in Hepatology Departments: A Survey of Nurses in Japan. Healthcare (Basel) 2021;9:1021. [PMID: 34442158 DOI: 10.3390/healthcare9081021] [Reference Citation Analysis]
40 Kikuchi N, Uojima H, Hidaka H, Iwasaki S, Wada N, Kubota K, Nakazawa T, Shibuya A, Fujikawa T, Kako M, Sato T, Koizumi W. Prospective study for an independent predictor of prognosis in liver cirrhosis based on the new sarcopenia criteria produced by the Japan Society of Hepatology. Hepatol Res 2021;51:968-78. [PMID: 34269502 DOI: 10.1111/hepr.13698] [Reference Citation Analysis]
41 Feng H, Wang X, Mao L, Yu Z, Cui B, Lin L, Hui Y, Zhao X, Xu X, Fan X, Wang B, Yu Q, Jiang K, Sun C. Relationship between sarcopenia/myosteatosis and frailty in hospitalized patients with cirrhosis: a sex-stratified analysis. Ther Adv Chronic Dis 2021;12:20406223211026996. [PMID: 34377386 DOI: 10.1177/20406223211026996] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
42 Nishikawa H, Shiraki M, Hiramatsu A, Hara N, Moriya K, Hino K, Koike K. Reduced handgrip strength predicts poorer survival in chronic liver diseases: A large multicenter study in Japan. Hepatol Res 2021;51:957-67. [PMID: 34057800 DOI: 10.1111/hepr.13679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
43 Dag N, Karatoprak S, Ozturk M, Karatoprak NB, Sigirci A, Yilmaz S. Investigation of the prognostic value of psoas muscle area measurement in pediatric patients before liver transplantation: A single-center retrospective study. Clin Transplant 2021. [PMID: 34231257 DOI: 10.1111/ctr.14416] [Reference Citation Analysis]
44 Yoshiji H, Nagoshi S, Akahane T, Asaoka Y, Ueno Y, Ogawa K, Kawaguchi T, Kurosaki M, Sakaida I, Shimizu M, Taniai M, Terai S, Nishikawa H, Hiasa Y, Hidaka H, Miwa H, Chayama K, Enomoto N, Shimosegawa T, Takehara T, Koike K. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. J Gastroenterol 2021;56:593-619. [PMID: 34231046 DOI: 10.1007/s00535-021-01788-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 34.0] [Reference Citation Analysis]
45 Al-Azzawi Y, Albo B, Fasullo M, Coukos J, Watts GJ, Tai R, Radcliffe D, Kroll-Desrosiers A, Devuni D, Szabo G. Sarcopenia is associated with longer hospital stay and multiorgan dysfunction in alcoholic hepatitis. Eur J Gastroenterol Hepatol 2020;32:733-8. [PMID: 31834050 DOI: 10.1097/MEG.0000000000001583] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
46 Frenette CT, Levy C, Saab S. Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door. Dig Dis Sci 2021. [PMID: 34169435 DOI: 10.1007/s10620-021-07075-2] [Reference Citation Analysis]
47 Nishikawa H, Yoh K, Enomoto H, Ikeda N, Takashima T, Aizawa N, Nishimura T, Nishiguchi S, Iijima H. Predictors for Grip Strength Loss in Patients With Chronic Liver Diseases. In Vivo 2021;35:363-71. [PMID: 33402485 DOI: 10.21873/invivo.12267] [Reference Citation Analysis]
48 Li T, Xu M, Kong M, Song W, Duan Z, Chen Y. Use of skeletal muscle index as a predictor of short-term mortality in patients with acute-on-chronic liver failure. Sci Rep 2021;11:12593. [PMID: 34131260 DOI: 10.1038/s41598-021-92087-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Kyrana E. Significance of sarcopenia in children with end-stage liver disease undergoing liver transplantation. Pediatr Transplant 2021;25:e14038. [PMID: 34120403 DOI: 10.1111/petr.14038] [Reference Citation Analysis]
50 Campbell KA, Trivedi HD, Chopra S. Infections in Cirrhosis: A Guide for the Clinician. Am J Med 2021;134:727-34. [PMID: 33607090 DOI: 10.1016/j.amjmed.2021.01.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Li TH, Liu CW, Huang CC, Tsai YL, Huang SF, Yang YY, Tsai CY, Hou MC, Lin HC. Non-Selective Beta-Blockers Decrease Infection, Acute Kidney Injury Episodes, and Ameliorate Sarcopenic Changes in Patients with Cirrhosis: A Propensity-Score Matching Tertiary-Center Cohort Study. J Clin Med 2021;10:2244. [PMID: 34064207 DOI: 10.3390/jcm10112244] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Shimada M, Hirashima N, Iwase H, Saito M, Kondo H, Urata N, Unita S, Kondo T, Tanaka D, Tsunekawa T, Fujishiro M. Evaluation of Muscle Cramp Associated with Liver Cirrhosis with a Focus on the Liver Function and Nutritional Status. Intern Med 2021;60:1343-8. [PMID: 33281163 DOI: 10.2169/internalmedicine.6231-20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Maddox SS, Palines PA, Hoffman RD, Danos DM, Womac DJ, Tuggle CT, Stalder MW. A Novel Technique for Radiographic Diagnosis of Sarcopenia that Accurately Predicts Postoperative Complications in Lower Extremity Free Flap Patients. J Reconstr Microsurg 2021. [PMID: 33853127 DOI: 10.1055/s-0041-1726396] [Reference Citation Analysis]
54 Nishikawa H, Yoh K, Enomoto H, Nishimura T, Nishiguchi S, Iijima H. Clinical impact of the finger-circle test in patients with liver diseases. Hepatol Res 2021;51:603-13. [PMID: 33772972 DOI: 10.1111/hepr.13639] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Nishikawa H, Yoh K, Enomoto H, Nishimura T, Nishiguchi S, Iijima H. Combined grip strength and calf circumference as a useful prognostic system in patients with liver diseases: a large cohort study. Ann Transl Med 2021;9:624. [PMID: 33987322 DOI: 10.21037/atm-20-6901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Kim Y. Emerging Treatment Options for Sarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:250. [PMID: 33803020 DOI: 10.3390/life11030250] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
57 Li GH, Lee GK, Au PC, Chan M, Li HL, Cheung BM, Wong IC, Lee VH, Mok J, Yip BH, Cheng KK, Wu CH, Cheung CL. The effect of different measurement modalities in the association of lean mass with mortality: A systematic review and meta-analysis. Osteoporos Sarcopenia 2021;7:S13-8. [PMID: 33997304 DOI: 10.1016/j.afos.2021.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Koon-Yee Lee G, Chun-Ming Au P, Hoi-Yee Li G, Chan M, Li HL, Man-Yung Cheung B, Chi-Kei Wong I, Ho-Fun Lee V, Mok J, Hon-Kei Yip B, King-Yip Cheng K, Wu CH, Cheung CL. Sarcopenia and mortality in different clinical conditions: A meta-analysis. Osteoporos Sarcopenia 2021;7:S19-27. [PMID: 33997305 DOI: 10.1016/j.afos.2021.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
59 Cheung CL, Lee GK, Au PC, Li GH, Chan M, Li HL, Cheung BM, Wong IC, Lee VH, Mok J, Yip BH, Cheng KK, Wu CH. Systematic review and meta-analysis of lean mass and mortality: Rationale and study description. Osteoporos Sarcopenia 2021;7:S3-S12. [PMID: 33997303 DOI: 10.1016/j.afos.2021.01.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
60 Young S, Larson L, Bermudez J, Mohei H, Rostambeigi N, Golzarian J, Mahgoub A. Evaluation of the frequency and factors predictive of hernia incarceration following transjugular intrahepatic portosystemic shunt placement. Clin Radiol 2021;76:287-93. [PMID: 33549300 DOI: 10.1016/j.crad.2020.12.014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Lee GH, Cho HJ, Lee G, Kim HG, Wang HJ, Kim BW, Lee MY, Yoon SY, Noh CK, Seo CW, Eun JW, Cheong JY, Cho SW, Kim SS. Bioelectrical impedance analysis for predicting postoperative complications and survival after liver resection for hepatocellular carcinoma. Ann Transl Med 2021;9:190. [PMID: 33708817 DOI: 10.21037/atm-20-5194] [Reference Citation Analysis]
62 Hey P, Gow P, Testro AG, Apostolov R, Chapman B, Sinclair M. Nutraceuticals for the treatment of sarcopenia in chronic liver disease. Clin Nutr ESPEN 2021;41:13-22. [PMID: 33487256 DOI: 10.1016/j.clnesp.2020.11.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
63 Lee CM, Kang BK, Kim M. Radiologic Definition of Sarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:86. [PMID: 33504046 DOI: 10.3390/life11020086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
64 Lee CM, Kang BK, Kim M. Radiologic Definition of Sarcopenia in Chronic Liver Disease.Life (Basel). 2021;11. [PMID: 33504046 DOI: 10.3390/life11020086.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Metzger GA, Carsel A, Sebastião YV, Deans KJ, Minneci PC. Does sarcopenia affect outcomes in pediatric surgical patients? A scoping review. J Pediatr Surg 2021:S0022-3468(21)00029-4. [PMID: 33500162 DOI: 10.1016/j.jpedsurg.2021.01.009] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
66 Kurosawa T, Goto M, Kaji N, Aikiyo S, Mihara T, Ikemoto-Uezumi M, Toyoda M, Kanazawa N, Nakazawa T, Hori M, Uezumi A. Liver fibrosis-induced muscle atrophy is mediated by elevated levels of circulating TNFα. Cell Death Dis 2021;12:11. [PMID: 33414474 DOI: 10.1038/s41419-020-03353-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
67 Marasco G, Sadalla S, Vara G, Golfieri R, Festi D, Colecchia A, Renzulli M. Imaging Software-Based Sarcopenia Assessment in Gastroenterology: Evolution and Clinical Meaning. Can J Gastroenterol Hepatol. 2021;2021:6669480. [PMID: 33505942 DOI: 10.1155/2021/6669480] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
68 Paternostro R, Bardach C, Hofer BS, Scheiner B, Schwabl P, Asenbaum U, Ba-Ssalamah A, Scharitzer M, Bucscis T, Simbrunner B, Bauer D, Trauner M, Mandorfer M, Reiberger T, Lampichler K. Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension. Liver Int. 2021;41:799-809. [PMID: 33290614 DOI: 10.1111/liv.14758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
69 Xu XY, Ding HG, Li WG, Xu JH, Han Y, Jia JD, Wei L, Duan ZP, Ling-Hu EQ, Zhuang H. Chinese guidelines on the management of liver cirrhosis (abbreviated version) . World J Gastroenterol 2020; 26(45): 7088-7103 [PMID: 33362370 DOI: 10.3748/wjg.v26.i45.7088] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
70 Merli M. Nutrition in cirrhosis: Dos and Don’ts. Journal of Hepatology 2020;73:1563-5. [DOI: 10.1016/j.jhep.2020.07.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Endo K, Sato T, Kakisaka K, Takikawa Y. Calf and arm circumference as simple markers for screening sarcopenia in patients with chronic liver disease. Hepatol Res 2021;51:176-89. [PMID: 33141991 DOI: 10.1111/hepr.13589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
72 Zager Y, Khalilieh S, Ganaiem O, Gorgov E, Horesh N, Anteby R, Kopylov U, Jacoby H, Dreznik Y, Dori A, Gutman M, Nevler A. Low psoas muscle area is associated with postoperative complications in Crohn's disease. Int J Colorectal Dis 2021;36:543-50. [PMID: 33236229 DOI: 10.1007/s00384-020-03799-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
73 Xu L, Jing Y, Zhao C, Zhang Q, Zhao X, Yang J, Wu L, Yang Y. Preoperative computed tomography-assessed skeletal muscle index is a novel prognostic factor in patients with hepatocellular carcinoma following hepatectomy: a meta-analysis. J Gastrointest Oncol 2020;11:1040-53. [PMID: 33209496 DOI: 10.21037/jgo-20-122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
74 Lee J, Jeong WK, Kim JH, Kim JM, Kim TY, Choi GS, Kwon CHD, Joh JW, Eom SY. Serial Observations of Muscle and Fat Mass as Prognostic Factors for Deceased Donor Liver Transplantation. Korean J Radiol 2021;22:189-97. [PMID: 33236536 DOI: 10.3348/kjr.2019.0750] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
75 Abrigo J, Campos F, Gonzalez F, Aguirre F, Gonzalez A, Huerta-Salgado C, Conejeros S, Simon F, Arrese M, Cabrera D, Elorza AA, Cabello-Verrugio C. Sarcopenia Induced by Chronic Liver Disease in Mice Requires the Expression of the Bile Acids Membrane Receptor TGR5. Int J Mol Sci 2020;21:E7922. [PMID: 33113850 DOI: 10.3390/ijms21217922] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
76 Altajar S, Baffy G. Skeletal Muscle Dysfunction in the Development and Progression of Nonalcoholic Fatty Liver Disease. J Clin Transl Hepatol 2020;8:414-23. [PMID: 33447525 DOI: 10.14218/JCTH.2020.00065] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
77 Ohashi K, Ishikawa T, Imai M, Suzuki M, Hoshii A, Abe H, Koyama F, Nakano T, Ueki A, Noguchi H, Hasegawa E, Hirosawa S, Kobayashi M, Hirosawa H, Sato K, Munakata M, Yoshida T. Relationship between pre-sarcopenia and quality of life in patients with chronic liver disease: a cross-sectional study. Eur J Gastroenterol Hepatol 2019;31:1408-13. [PMID: 30964810 DOI: 10.1097/MEG.0000000000001415] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
78 Dos Santos ALS, Anastácio LR. The impact of L-branched-chain amino acids and L-leucine on malnutrition, sarcopenia, and other outcomes in patients with chronic liver disease. Expert Rev Gastroenterol Hepatol 2021;15:181-94. [PMID: 32993404 DOI: 10.1080/17474124.2021.1829470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 Puri P, Dhiman RK, Taneja S, Tandon P, Merli M, Anand AC, Arora A, Acharya SK, Benjamin J, Chawla YK, Dadhich S, Duseja A, Eapan CE, Goel A, Kalra N, Kapoor D, Kumar A, Madan K, Nagral A, Pandey G, Rao PN, Saigal S, Saraf N, Saraswat VA, Saraya A, Sarin SK, Sharma P, Shalimar, Shukla A, Sidhu SS, Singh N, Singh SP, Srivastava A, Wadhawan M. Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver. J Clin Exp Hepatol 2021;11:97-143. [PMID: 33679050 DOI: 10.1016/j.jceh.2020.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
80 Zhao M, Zhou X, Yuan C, Li R, Ma Y, Tang X. Association between serum irisin concentrations and sarcopenia in patients with liver cirrhosis: a cross-sectional study. Sci Rep. 2020;10:16093. [PMID: 32999391 DOI: 10.1038/s41598-020-73176-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
81 Kukla M, Skladany L, Menżyk T, Derra A, Stygar D, Skonieczna M, Hudy D, Nabrdalik K, Gumprecht J, Marlicz W, Koulaouzidis A, Koller T. Irisin in Liver Cirrhosis. J Clin Med 2020;9:E3158. [PMID: 33003490 DOI: 10.3390/jcm9103158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
82 Wang NC, Zhang P, Tapper EB, Saini S, Wang SC, Su GL. Automated Measurements of Muscle Mass Using Deep Learning Can Predict Clinical Outcomes in Patients With Liver Disease. Am J Gastroenterol. 2020;115:1210-1216. [PMID: 32467506 DOI: 10.14309/ajg.0000000000000662] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
83 Xia L, Zhao R, Wan Q, Wu Y, Zhou Y, Wang Y, Cui Y, Shen X, Wu X. Sarcopenia and adverse health-related outcomes: An umbrella review of meta-analyses of observational studies. Cancer Med 2020;9:7964-78. [PMID: 32924316 DOI: 10.1002/cam4.3428] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 22.0] [Reference Citation Analysis]
84 Ufuk F, Demirci M, Sagtas E, Akbudak IH, Ugurlu E, Sari T. The prognostic value of pneumonia severity score and pectoralis muscle Area on chest CT in adult COVID-19 patients. Eur J Radiol 2020;131:109271. [PMID: 32942198 DOI: 10.1016/j.ejrad.2020.109271] [Cited by in Crossref: 17] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
85 Deng L, Wang Y, Zhao J, Tong Y, Zhang S, Jin C, Chen K, Bao W, Yu Z, Chen G. The prognostic value of sarcopenia combined with hepatolithiasis in intrahepatic cholangiocarcinoma patients after surgery: A prospective cohort study. Eur J Surg Oncol 2021;47:603-12. [PMID: 32933804 DOI: 10.1016/j.ejso.2020.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
86 Solà E, Pose E, Campion D, Piano S, Roux O, Simon-Talero M, Uschner F, de Wit K, Zaccherini G, Alessandria C, Beuers U, Caraceni P, Francoz C, Mookerjee RP, Trebicka J, Vargas V, Serra M, Torres F, Montagnese S, Krag A, Hernaez R, Korenjak M, Watson H, Abraldes JG, Kamath PS, Ginès P; LiverHope Consortium Investigators. Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium. J Hepatol 2021;74:200-19. [PMID: 32896580 DOI: 10.1016/j.jhep.2020.08.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
87 Marasco G, Serenari M, Renzulli M, Alemanni LV, Rossini B, Pettinari I, Dajti E, Ravaioli F, Golfieri R, Cescon M, Festi D, Colecchia A. Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments. J Gastroenterol 2020;55:927-43. [PMID: 32748172 DOI: 10.1007/s00535-020-01711-w] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 13.0] [Reference Citation Analysis]
88 Kim BJ, Ahn SH, Lee SH, Hong S, Hamrick MW, Isales CM, Koh JM. Lower hand grip strength in older adults with non-alcoholic fatty liver disease: a nationwide population-based study. Aging (Albany NY) 2019;11:4547-60. [PMID: 31280255 DOI: 10.18632/aging.102068] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
89 Simonetto DA, Shah VH, Kamath PS. Outpatient management of alcohol-related liver disease. Lancet Gastroenterol Hepatol 2020;5:485-93. [PMID: 32277901 DOI: 10.1016/S2468-1253(19)30415-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
90 Grutters LA, Pennings JP, Bruggink JL, Viddeleer AR, Verkade HJ, de Kleine RH, de Haas RJ. Body Composition of Infants With Biliary Atresia: Anthropometric Measurements and Computed Tomography-based Body Metrics. Journal of Pediatric Gastroenterology & Nutrition 2020;71:440-5. [DOI: 10.1097/mpg.0000000000002859] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
91 Ebadi M, Bhanji RA, Tandon P, Mazurak V, Baracos VE, Montano-Loza AJ. Review article: prognostic significance of body composition abnormalities in patients with cirrhosis. Aliment Pharmacol Ther 2020;52:600-18. [PMID: 32621329 DOI: 10.1111/apt.15927] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
92 Aguirre F, Abrigo J, Gonzalez F, Gonzalez A, Simon F, Cabello-Verrugio C. Protective Effect of Angiotensin 1-7 on Sarcopenia Induced by Chronic Liver Disease in Mice. Int J Mol Sci 2020;21:E3891. [PMID: 32485991 DOI: 10.3390/ijms21113891] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
93 Nóbrega SR, Chachá SGF, Libardi CA. Resistance training combined with blood flow restriction in cirrhosis: study protocol for a randomized controlled trial. Trials 2020;21:446. [PMID: 32471480 DOI: 10.1186/s13063-020-04410-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
94 Zambrano DN, Xiao J, Prado CM, Gonzalez MC. Patient-Generated Subjective Global Assessment and Computed Tomography in the assessment of malnutrition and sarcopenia in patients with cirrhosis: Is there any association? Clinical Nutrition 2020;39:1535-40. [DOI: 10.1016/j.clnu.2019.06.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
95 Oliveira VHF, Borsari AL, Webel AR, Erlandson KM, Deminice R. Sarcopenia in people living with the Human Immunodeficiency Virus: a systematic review and meta-analysis. Eur J Clin Nutr 2020;74:1009-21. [PMID: 32341489 DOI: 10.1038/s41430-020-0637-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
96 Woodward AJ, Avery A, Keating SE, Ward LC, Coombes JS, Macdonald GA. Computerised tomography skeletal muscle and adipose surface area values in a healthy Caucasian population. Eur J Clin Nutr 2020;74:1276-81. [PMID: 32327731 DOI: 10.1038/s41430-020-0628-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
97 Yoh K, Nishikawa H, Enomoto H, Iwata Y, Ikeda N, Aizawa N, Nishimura T, Iijima H, Nishiguchi S. Grip Strength: A Useful Marker for Composite Hepatic Events in Patients with Chronic Liver Diseases. Diagnostics (Basel) 2020;10:E238. [PMID: 32325995 DOI: 10.3390/diagnostics10040238] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
98 Pacifico L, Perla FM, Andreoli G, Grieco R, Pierimarchi P, Chiesa C. Nonalcoholic Fatty Liver Disease Is Associated With Low Skeletal Muscle Mass in Overweight/Obese Youths. Front Pediatr 2020;8:158. [PMID: 32351917 DOI: 10.3389/fped.2020.00158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
99 Cushing KC, Kordbacheh H, Gee MS, Kambadakone A, Ananthakrishnan AN. Sarcopenia is a Novel Predictor of the Need for Rescue Therapy in Hospitalized Ulcerative Colitis Patients. J Crohns Colitis. 2018;. [PMID: 29762697 DOI: 10.1093/ecco-jcc/jjy064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
100 Vural A, Attaway A, Welch N, Zein J, Dasarathy S. Skeletal muscle loss phenotype in cirrhosis: A nationwide analysis of hospitalized patients. Clin Nutr 2020;39:3711-20. [PMID: 32303380 DOI: 10.1016/j.clnu.2020.03.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
101 Taylor SA, Venkat V, Arnon R, Gopalareddy VV, Rosenthal P, Erinjeri J, Anand R, Daniel JF. Improved Outcomes for Liver Transplantation in Patients with Biliary Atresia Since Pediatric End-Stage Liver Disease Implementation: Analysis of the Society of Pediatric Liver Transplantation Registry. The Journal of Pediatrics 2020;219:89-97. [DOI: 10.1016/j.jpeds.2019.12.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
102 Traub J, Bergheim I, Eibisberger M, Stadlbauer V. Sarcopenia and Liver Cirrhosis-Comparison of the European Working Group on Sarcopenia Criteria 2010 and 2019. Nutrients. 2020;12:547. [PMID: 32093198 DOI: 10.3390/nu12020547] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
103 Hwang Y, Lee YH, Cho DH, Kim M, Lee DS, Cho HJ. Applicability of the masseter muscle as a nutritional biomarker. Medicine (Baltimore) 2020;99:e19069. [PMID: 32028430 DOI: 10.1097/MD.0000000000019069] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
104 Endo K, Sato T, Suzuki A, Yoshida Y, Kakisaka K, Miyasaka A, Takikawa Y. Sustained virologic response by direct-acting antivirals suppresses skeletal muscle loss in hepatitis C virus infection. J Gastroenterol Hepatol. 2020;35:1602-1609. [PMID: 31975438 DOI: 10.1111/jgh.14991] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
105 Welch N, Dasarathy J, Runkana A, Penumatsa R, Bellar A, Reen J, Rotroff D, McCullough AJ, Dasarathy S. Continued muscle loss increases mortality in cirrhosis: Impact of aetiology of liver disease. Liver Int 2020;40:1178-88. [PMID: 31889396 DOI: 10.1111/liv.14358] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
106 Georgiou A, Papatheodoridis GV, Alexopoulou A, Deutsch M, Vlachogiannakos I, Ioannidou P, Papageorgiou MV, Papadopoulos N, Yannakoulia M, Kontogianni MD. Validation of cutoffs for skeletal muscle mass index based on computed tomography analysis against dual energy X-ray absorptiometry in patients with cirrhosis: the KIRRHOS study. Ann Gastroenterol. 2020;33:80-86. [PMID: 31892802 DOI: 10.20524/aog.2019.0432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
107 Kim JA, Choi KM. Sarcopenia and fatty liver disease. Hepatol Int. 2019;13:674-687. [PMID: 31705444 DOI: 10.1007/s12072-019-09996-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 12.0] [Reference Citation Analysis]
108 Bunchorntavakul C, Reddy KR. Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis. Aliment Pharmacol Ther 2020;51:64-77. [PMID: 31701570 DOI: 10.1111/apt.15571] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 18.3] [Reference Citation Analysis]
109 Ozola-zālīte I, Frøkjær JB, Mark EB, Gudauskas T, Gudauskas L, Dedelaite M, Bieliuniene E, Ignatavicius P, Pukitis A, Drewes AM, Olesen SS. A Clinical Feasible Method for Computed Tomography-Based Assessment of Sarcopenia in Patients With Chronic Pancreatitis. Pancreas 2019;48:1354-9. [DOI: 10.1097/mpa.0000000000001439] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
110 Carey EJ, Lai JC, Sonnenday C, Tapper EB, Tandon P, Duarte-Rojo A, Dunn MA, Tsien C, Kallwitz ER, Ng V, Dasarathy S, Kappus M, Bashir MR, Montano-Loza AJ. A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation. Hepatology 2019;70:1816-29. [PMID: 31220351 DOI: 10.1002/hep.30828] [Cited by in Crossref: 108] [Cited by in F6Publishing: 99] [Article Influence: 36.0] [Reference Citation Analysis]
111 Martínez-Arnau FM, Fonfría-Vivas R, Cauli O. Beneficial Effects of Leucine Supplementation on Criteria for Sarcopenia: A Systematic Review. Nutrients 2019;11:E2504. [PMID: 31627427 DOI: 10.3390/nu11102504] [Cited by in Crossref: 25] [Cited by in F6Publishing: 38] [Article Influence: 8.3] [Reference Citation Analysis]
112 Yao CK, Fung J, Chu NHS, Tan VPY. Dietary Interventions in Liver Cirrhosis. J Clin Gastroenterol. 2018;52:663-673. [PMID: 29912757 DOI: 10.1097/mcg.0000000000001071] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
113 Nardelli S, Gioia S, Faccioli J, Riggio O, Ridola L. Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy. World J Gastroenterol 2019; 25(35): 5257-5265 [PMID: 31558871 DOI: 10.3748/wjg.v25.i35.5257] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
114 Paternostro R, Lampichler K, Bardach C, Asenbaum U, Landler C, Bauer D, Mandorfer M, Schwarzer R, Trauner M, Reiberger T, Ferlitsch A. The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis. Liver Int. 2019;39:2374-2385. [PMID: 31421002 DOI: 10.1111/liv.14217] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 5.7] [Reference Citation Analysis]
115 Dhaliwal A, Towey J, Lord JM, Armstrong M, Elsharkawy AM. Nutrition in liver cirrhosis: a case-based overview. Frontline Gastroenterol 2020;11:155-61. [PMID: 32133115 DOI: 10.1136/flgastro-2018-101121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
116 Shalimar, Sheikh MF, Mookerjee RP, Agarwal B, Acharya SK, Jalan R. Prognostic Role of Ammonia in Patients With Cirrhosis. Hepatology 2019;70:982-94. [PMID: 30703853 DOI: 10.1002/hep.30534] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 15.3] [Reference Citation Analysis]
117 Sinclair M, Chapman B, Hoermann R, Angus PW, Testro A, Scodellaro T, Gow PJ. Handgrip Strength Adds More Prognostic Value to the Model for End-Stage Liver Disease Score Than Imaging-Based Measures of Muscle Mass in Men With Cirrhosis. Liver Transpl. 2019;25:1480-1487. [PMID: 31282126 DOI: 10.1002/lt.25598] [Cited by in Crossref: 27] [Cited by in F6Publishing: 41] [Article Influence: 9.0] [Reference Citation Analysis]
118 Ebadi M, Bhanji RA, Mazurak VC, Montano-Loza AJ. Sarcopenia in cirrhosis: from pathogenesis to interventions. J Gastroenterol 2019;54:845-59. [PMID: 31392488 DOI: 10.1007/s00535-019-01605-6] [Cited by in Crossref: 79] [Cited by in F6Publishing: 74] [Article Influence: 26.3] [Reference Citation Analysis]
119 Newman KL, Johnson KM, Cornia PB, Wu P, Itani K, Ioannou GN. Perioperative Evaluation and Management of Patients With Cirrhosis: Risk Assessment, Surgical Outcomes, and Future Directions. Clin Gastroenterol Hepatol 2020;18:2398-2414.e3. [PMID: 31376494 DOI: 10.1016/j.cgh.2019.07.051] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
120 Samji NS, Verma R, Keri KC, Singal AK, Ahmed A, Rinella M, Bernstein D, Abdelmalek MF, Satapathy SK. Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges. Dig Dis Sci 2019;64:3413-30. [PMID: 31312990 DOI: 10.1007/s10620-019-05716-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
121 Wijarnpreecha K, Werlang M, Panjawatanan P, Kroner PT, Cheungpasitporn W, Lukens FJ, Pungpapong S, Ungprasert P. Association between sarcopenia and hepatic encephalopathy: A systematic review and meta-analysis. Ann Hepatol 2020;19:245-50. [PMID: 31422030 DOI: 10.1016/j.aohep.2019.06.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
122 Ahn JC, Sundaram V. Obesity and Liver Decompensation. Clin Liver Dis (Hoboken) 2019;14:12-5. [PMID: 31391930 DOI: 10.1002/cld.807] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
123 Farkas ZC, Rashid T, Chen YS, Siddiqui TM, Yandrapalli S, Frager S, Aronow WS, Bodin R, Maddineni S. The correlation between sarcopaenia and post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy: a single-institution review. Arch Med Sci Atheroscler Dis. 2019;4:e89-e93. [PMID: 31211275 DOI: 10.5114/amsad.2019.85380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
124 Hahn F, Müller L, Stöhr F, Mähringer‐kunz A, Schotten S, Düber C, Bartsch F, Lang H, Galle PR, Weinmann A, Kloeckner R. The role of sarcopenia in patients with intrahepatic cholangiocarcinoma: Prognostic marker or hyped parameter? Liver Int 2019;39:1307-14. [DOI: 10.1111/liv.14132] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
125 Mazzarelli C, Prentice WM, Heneghan MA, Belli LS, Agarwal K, Cannon MD. Palliative care in end-stage liver disease: Time to do better? Liver Transpl 2018;24:961-8. [PMID: 29729119 DOI: 10.1002/lt.25193] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
126 Zhu ZR, Liu WL, Ding ZM, Li Y. Efficacy of furosemide for treatment of liver cirrhosis: A systematic review protocol of randomized controlled trial. Medicine (Baltimore) 2019;98:e15300. [PMID: 31008980 DOI: 10.1097/MD.0000000000015300] [Reference Citation Analysis]
127 Jindal A, Jagdish RK. Sarcopenia: Ammonia metabolism and hepatic encephalopathy. Clin Mol Hepatol. 2019;. [PMID: 31006226 DOI: 10.3350/cmh.2019.0015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
128 Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S. Serum Zinc Concentration and Sarcopenia: A Close Linkage in Chronic Liver Diseases. J Clin Med 2019;8:E336. [PMID: 30862022 DOI: 10.3390/jcm8030336] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
129 Chang KV, Chen JD, Wu WT, Huang KC, Han DS. Association of loss of muscle mass with mortality in liver cirrhosis without or before liver transplantation: A systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e14373. [PMID: 30817561 DOI: 10.1097/MD.0000000000014373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
130 Sinclair M, Hoermann R, Peterson A, Testro A, Angus PW, Hey P, Chapman B, Gow PJ. Use of Dual X-ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia-associated mortality risk. Liver Int 2019;39:1089-97. [PMID: 30746903 DOI: 10.1111/liv.14071] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
131 Sinha R. Editorial: moving towards a robust definition of sarcopenia in cirrhosis. Aliment Pharmacol Ther 2019;49:340-1. [PMID: 30663102 DOI: 10.1111/apt.15070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
132 Montgomery J, Englesbe M. Sarcopenia in Liver Transplantation. Curr Transplant Rep 2019;6:7-15. [PMID: 31595213 DOI: 10.1007/s40472-019-0223-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
133 Byun SE, Kim S, Kim KH, Ha YC. Psoas cross-sectional area as a predictor of mortality and a diagnostic tool for sarcopenia in hip fracture patients. J Bone Miner Metab 2019;37:871-9. [PMID: 30623251 DOI: 10.1007/s00774-019-00986-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
134 Koya S, Kawaguchi T, Hashida R, Hirota K, Bekki M, Goto E, Yamada M, Sugimoto M, Hayashi S, Goshima N, Yoshiyama T, Otsuka T, Nozoe R, Nagamatsu A, Nakano D, Shirono T, Shimose S, Iwamoto H, Niizeki T, Matsuse H, Koga H, Miura H, Shiba N, Torimura T. Effects of in-hospital exercise on sarcopenia in hepatoma patients who underwent transcatheter arterial chemoembolization. J Gastroenterol Hepatol 2019;34:580-8. [PMID: 30402913 DOI: 10.1111/jgh.14538] [Cited by in Crossref: 7] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
135 Chae M, Kim Y, Kim J, Ko Y, Jung J, Choi H, Chung H, Hong S, Park C, Choi J, Huh J. Perioperative Changes in the Psoas Muscle Index in Patients Undergoing ABO-Incompatible Living-Donor Liver Transplantation: A Single-Center Experience. Transplantation Proceedings 2018;50:3656-60. [DOI: 10.1016/j.transproceed.2018.08.034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
136 Jang TY, Yeh ML, Huang CI, Lin ZY, Chen SC, Hsieh MH, Dai CY, Huang JF, Huang CF, Chuang WL, Yu ML. Association of hyperuricemia with disease severity in chronic hepatitis C patients. PLoS One 2018;13:e0207043. [PMID: 30395654 DOI: 10.1371/journal.pone.0207043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
137 Hsu C, Kao J. Sarcopenia and chronic liver diseases. Expert Review of Gastroenterology & Hepatology 2018;12:1229-44. [DOI: 10.1080/17474124.2018.1534586] [Cited by in Crossref: 26] [Cited by in F6Publishing: 40] [Article Influence: 6.5] [Reference Citation Analysis]
138 Surov A, Paul L, Meyer HJ, Schob S, Engelmann C, Wienke A. Apparent Diffusion Coefficient Is a Novel Imaging Biomarker of Myopathic Changes in Liver Cirrhosis. J Clin Med. 2018;7:359. [PMID: 30326652 DOI: 10.3390/jcm7100359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
139 Cawthon PM. Recent Progress in Sarcopenia Research: a Focus on Operationalizing a Definition of Sarcopenia. Curr Osteoporos Rep 2018;16:730-7. [DOI: 10.1007/s11914-018-0484-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
140 Han J, Kim W. Prognostic implications of trunk muscle mass in liver cirrhosis. Clin Mol Hepatol 2018;24:297-8. [PMID: 30196650 DOI: 10.3350/cmh.2018.0069] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
141 De Bandt JP, Jegatheesan P, Tennoune-El-Hafaia N. Muscle Loss in Chronic Liver Diseases: The Example of Nonalcoholic Liver Disease. Nutrients 2018;10:E1195. [PMID: 30200408 DOI: 10.3390/nu10091195] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
142 Ebadi M, Montano-loza AJ. Insights on clinical relevance of sarcopenia in patients with cirrhosis and sepsis. Liver Int 2018;38:786-8. [DOI: 10.1111/liv.13720] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
143 Kok B, Tandon P. Frailty in Patients With Cirrhosis. Curr Treat Options Gastroenterol. 2018;16:215-225. [PMID: 29589278 DOI: 10.1007/s11938-018-0179-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
144 Lee TH. Nutritional Assessment and Management for Patients with Chronic Liver Disease. Korean J Gastroenterol 2018;71:185. [DOI: 10.4166/kjg.2018.71.4.185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]